Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

Clinical trial NCT06247826 · RECRUITING

Trial details

NCT number: NCT06247826
Sponsor: Groupe Francais De Pneumo-Cancerologie
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer EGFR Exon 20 Insertion Mutation

Start date: 2024-01-15
Primary completion: 2026-07-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.